Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Viruses|December 20, 2013
Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceMichael S Bennett, Ramesh AkkinaOligonucleotides|March 6, 2004
Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistanceJoseph Anderson, Akhil Banerjea, Ramesh AkkinaMethods in Molecular Biology (Clifton, N.J.)|December 31, 2015
Modeling HIV-1 Mucosal Transmission and Prevention in Humanized MiceMilena Veselinovic, Paige Charlins, Ramesh AkkinaMethods in Molecular Biology (Clifton, N.J.)|February 2, 2019
Generation of High-Titer Pseudotyped Lentiviral VectorsShuang Hu, Mingjie Li, Ramesh AkkinaAIDS Research and Human Retroviruses|September 19, 2003
Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNAJoseph Anderson, Akhil Banerjea, Vicente Planelles, et al.Virology|November 20, 2009
Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a yearBradford K Berges, Sarah R Akkina, Leila Remling, et al.Retrovirology|April 21, 2006
Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapyJoseph S Anderson, Sriram Bandi, Dan S Kaufman, et al.Journal of Virology|December 14, 2012
Identification of novel influenza A virus proteins translated from PA mRNAYukiko Muramoto, Takeshi Noda, Eiryo Kawakami, et al.Virology|August 21, 2007
Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) miceJes G Kuruvilla, Ryan M Troyer, Shamala Devi, et al.Virology|July 27, 2012
Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse modelMilena Veselinovic, C Preston Neff, Leila R Mulder, et al.Pageof 8